Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trialLi Zhang, Mengzhao Wang, Xiangqun Song et al.|The Lancet Oncology|2012Cited by 228